Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027627 (
metastases
)
103,950
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Tumor metastasis
represents the main causes of cancer-related death. Our recent study showed that chemokine CCL18 secreted from tumor-associated macrophages regulates breast tumor metastasis, but the underlying mechanisms remain less clear. Here, we show that
ARF6 GTPase-activating protein
ACAP4
regulates CCL18-elicited breast cancer cell migration via the acetyltransferase PCAF-mediated acetylation. CCL18 stimulation elicited breast cancer cell migration and invasion via PCAF-dependent acetylation.
ACAP4
physically interacts with PCAF and is a cognate substrate of PCAF during CCL18 stimulation. The acetylation site of
ACAP4
by PCAF was mapped to Lys311 by mass spectrometric analyses. Importantly, dynamic acetylation of
ACAP4
is essential for CCL18-induced breast cancer cell migration and invasion, as overexpression of the persistent acetylation-mimicking or non-acetylatable
ACAP4
mutant blocked CCL18-elicited cell migration and invasion. Mechanistically, the acetylation of
ACAP4
at Lys311 reduced the lipid-binding activity of
ACAP4
to ensure a robust and dynamic cycling of ARF6-
ACAP4
complex with plasma membrane in response to CCL18 stimulation. Thus, these results present a previously undefined mechanism by which CCL18-elicited acetylation of the PH domain controls dynamic interaction between
ACAP4
and plasma membrane during breast cancer cell migration and invasion.
...
PMID:Acetylation of ACAP4 regulates CCL18-elicited breast cancer cell migration and invasion. 3039 69